Literature DB >> 16461996

Mastocytosis: the great masquerader.

James S W Kong1, Suzanne Teuber, Rosemary Hallett, M Eric Gershwin.   

Abstract

Variants of mastocytosis can present with puzzling cutaneous and systemic symptoms and signs that can result in an erroneous diagnosis of idiopathic urticaria or idiopathic anayphylaxis. The molecular basis of mastocytosis is now better understood, with updated classification based on distinct growth factor and oncogene abnormalities. Elicitation of a full history and careful attention to the skin examination will usually provide the clinician enough information to deduce that the condition is not simply chronic idiopathic urticaria.

Entities:  

Mesh:

Year:  2006        PMID: 16461996     DOI: 10.1385/CRIAI:30:1:053

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  47 in total

1.  Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.

Authors:  C Akin; A S Kirshenbaum; T Semere; A S Worobec; L M Scott; D D Metcalfe
Journal:  Exp Hematol       Date:  2000-02       Impact factor: 3.084

Review 2.  Systemic mastocytosis.

Authors:  Cem Akin; Dean D Metcalfe
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

3.  Photochemotherapy of dominant, diffuse, cutaneous mastocytosis.

Authors:  M L Smith; P W Orton; H Chu; W L Weston
Journal:  Pediatr Dermatol       Date:  1990-12       Impact factor: 1.588

Review 4.  Mastocytosis: current concepts in diagnosis and treatment.

Authors:  L Escribano; C Akin; M Castells; A Orfao; D D Metcalfe
Journal:  Ann Hematol       Date:  2002-11-29       Impact factor: 3.673

5.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Authors:  Sonia Varadaradjalou; Frédéric Féger; Nathalie Thieblemont; Nadine Ben Hamouda; Jean-Marie Pleau; Michel Dy; Michel Arock
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

6.  Cromolyn sodium in the management of systemic mastocytosis.

Authors:  R F Horan; A L Sheffer; K F Austen
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

7.  Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults.

Authors:  G Topar; C Staudacher; F Geisen; C Gabl; F Fend; M Herold; R Greil; P Fritsch; N Sepp
Journal:  Am J Clin Pathol       Date:  1998-03       Impact factor: 2.493

Review 8.  Mast cells in allergy and host defense.

Authors:  M L Taylor; D D Metcalfe
Journal:  Allergy Asthma Proc       Date:  2001 May-Jun       Impact factor: 2.587

Review 9.  Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.

Authors:  Bryan Hennessy; Francis Giles; Jorge Cortes; Susan O'brien; Alessandra Ferrajoli; Gladys Ossa; Guillermo Garcia-Manero; Stefan Faderl; Hagop Kantarjian; Srdan Verstovsek
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

10.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.

Authors:  B J Longley; D D Metcalfe; M Tharp; X Wang; L Tyrrell; S Z Lu; D Heitjan; Y Ma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more
  4 in total

1.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 3.  Contemporary challenges in mastocytosis.

Authors:  H David Pettigrew; Suzanne S Teuber; James S Kong; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  Current concepts on diagnosis and treatment of mastocytosis.

Authors:  D Magliacane; R Parente; M Triggiani
Journal:  Transl Med UniSa       Date:  2014-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.